These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32087035)

  • 21. Dupilumab for hand eczema.
    Zirwas MJ
    J Am Acad Dermatol; 2018 Jul; 79(1):167-169. PubMed ID: 29535032
    [No Abstract]   [Full Text] [Related]  

  • 22. Hand Eczema in Africa: Clinical Findings and Experiences from South-West Uganda.
    Mirembe SK; Mulyowa GK; Jaeger G; Ofenloch R; Diepgen TL; Weisshaar E
    Acta Derm Venereol; 2016 Mar; 96(3):388-9. PubMed ID: 26390834
    [No Abstract]   [Full Text] [Related]  

  • 23. Compositae dermatitis presenting as hand eczema.
    Fitzgerald DA; English JS
    Contact Dermatitis; 1992 Oct; 27(4):256-7. PubMed ID: 1451494
    [No Abstract]   [Full Text] [Related]  

  • 24. A severe case of IgA bullous pemphigoid successfully treated with dupilumab.
    Valenti M; De Giacomo P; Lavecchia A; Valenti G
    Dermatol Ther; 2022 Nov; 35(11):e15890. PubMed ID: 36181411
    [No Abstract]   [Full Text] [Related]  

  • 25. Dupilumab Treatment of Very Severe Refractory Atopic Hand Eczema.
    Oosterhaven JAF; Romeijn GLE; Schuttelaar MLA
    JAMA Dermatol; 2018 Aug; 154(8):969-970. PubMed ID: 29971331
    [No Abstract]   [Full Text] [Related]  

  • 26. Another case of dyshidrosiform pemphigoid.
    Patrizi A; Rizzoli L; Benassi L; Neri I
    J Eur Acad Dermatol Venereol; 2003 May; 17(3):370. PubMed ID: 12702100
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply to: 'Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab' by Baffa et al.
    Sun L; Brazão C; Mancha D; Soares-de-Almeida L; Filipe P
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):e578-e580. PubMed ID: 36681888
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful dupilumab treatment in bullous pemphigoid complicated with subacute hematogenous disseminated tuberculosis: A case report.
    Dong Q; Zheng R; He Z; Xi Y
    Skin Res Technol; 2024 Jul; 30(7):e13847. PubMed ID: 38995310
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe pemphigoid nodularis successfully treated with dupilumab.
    Jendoubi F; Bost C; Tournier E; Paul C; Konstantinou MP
    Dermatol Ther; 2022 Sep; 35(9):e15727. PubMed ID: 35861645
    [No Abstract]   [Full Text] [Related]  

  • 30. Hickam versus Ockham: atopic dermatitis and bullous pemphigoid or pemphigoid nodularis? Dupilumab solves the problem.
    Mutton T; Bocchi C; Gaban A; Marzola E; Schettini N; Borghi A
    Ital J Dermatol Venerol; 2024 Jun; 159(3):361-363. PubMed ID: 38695597
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment of chronic persistent vesicular hand dermatitis with topical pimecrolimus.
    Bukhari IA
    Saudi Med J; 2005 Dec; 26(12):1989-91. PubMed ID: 16380789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bullous pemphigoid manifesting as dyshidrotic eczema and prurigo nodularis].
    Braun B; Baima B; Sticherling M
    Hautarzt; 2002 Nov; 53(11):739-43. PubMed ID: 12402137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posttraumatic irritant contact dermatitis--an underdiagnosed entity?
    Darr-Foit S; Tittelbach J; Elsner P
    J Dtsch Dermatol Ges; 2014 Apr; 12(4):347-8. PubMed ID: 24119194
    [No Abstract]   [Full Text] [Related]  

  • 34. Dupilumab: A Review of Present Indications and Off-Label Uses.
    Muñoz-Bellido FJ; Moreno E; Dávila I
    J Investig Allergol Clin Immunol; 2022 Apr; 32(2):97-115. PubMed ID: 33661102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of hand eczema: clinical and aetiological types. Based on the guideline of the Danish Contact Dermatitis Group.
    Johansen JD; Hald M; Andersen BL; Laurberg G; Danielsen A; Avnstorp C; Kristensen B; Kristensen O; Kaaber K; Thormann J; Menné T; Veien N;
    Contact Dermatitis; 2011 Jul; 65(1):13-21. PubMed ID: 21658054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A successful case of vesicular pemphigoid concurrent with pulmonary tuberculosis with dupilumab.
    Shan Y; Zuo YG
    Dermatol Ther; 2022 Apr; 35(4):e15330. PubMed ID: 35080079
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dyshidrosiform bullous pemphigoid].
    Mohr C; Duschet P; Bonsmann G; Luger TA; Gschnait F; Schwarz T
    Hautarzt; 1993 Dec; 44(12):785-8. PubMed ID: 8113043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hand dermatitis: a review of clinical features, therapeutic options, and long-term outcomes.
    Warshaw E; Lee G; Storrs FJ
    Am J Contact Dermat; 2003 Sep; 14(3):119-37. PubMed ID: 14744403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of eczema-like bullous pemphigoid and typical bullous pemphigoid with dupilumab: two case reports.
    Xu Y; Song W; Cai Y; Huang R; Wei J; Liu H; Peng X; Zeng K; Li C
    Int J Dermatol; 2023 Mar; 62(3):e144-e146. PubMed ID: 36214412
    [No Abstract]   [Full Text] [Related]  

  • 40. Occupational Chronic Hand Dermatitis in Hospital Environment Successfully Treated with Dupilumab: A Case Report.
    Gan H; Gao YD
    Iran J Allergy Asthma Immunol; 2022 Aug; 21(4):484-487. PubMed ID: 36243937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.